FTAC Emerald Acquisition Corp. (NASDAQ: EMLD) announced that on March 16, it signed a non-binding letter of intent (LOI) to combine with an unnamed target.
With a completion deadline of June 20, FTAC Emerald was set to expire, but now that it has announced a signed LOI in hand, the company will receive an automatic extension of three months, giving it a new deadline of September 20.
The SPAC announced the pricing of its $220 million IPO in December 2021. It did not disclose further details on today’s potential merger or the target itself, but initially intended on combining with a target that achieves best-in-class standards in environmental, social, and governance (ESG) practices. FTAC Emerald is led by Chairman Betsy Cohen, President and CEO Bracebridge H. Young, Jr., Vice Chairman Mark Tercek, and CFO Doug Listman.
Because there is no guarantee that this LOI will be completed, FTAC Emerald will remain in SPACInsider’s “Searching” column until a definitive agreement is signed.
At the SPAC of Dawn It has clearly taken some time for SPACs to break out from their niche, but SPACs and de-SPACs are suddenly everywhere in current events. As the Russian invasion of Ukraine drags on, one of the most prolific SPAC teams has stepped forward with a letter of intent to take Ukraine’s...
Live Oak Acquisition Corp. V (NASDAQ:LOKVU) has filed for a $200 million IPO that brings another serial SPAC team back to the mix for a generalist search but with a pair of technology deals already in their pocket. The new S-1 also puts Santander on the board for the 2025 SPAC market after it made...
CH4 Natural Solutions (NYSE:MTNE.U) has filed for a $250 million SPAC to bring both the Riverstone sponsor team and underwriter Citigroup back to the market for 2025. The team secured notably sponsor-friendly terms for the vehicle and will not overfund its trust. In fact, along with fellow Friday filer Live Oak V (NASDAQ:LOKVU), these two...
At the SPAC of Dawn Amid a restive market, SPACs have front-loaded their business this week with three of their four votes set for today and tomorrow. One of these is a completion vote, in which Bowen (NASDAQ:BOWN) will try and secure shareholder approval for its combination with Shenzhen Qianzhi BioTechnology just after having gained...
Terms Tracker for the Week Ending January 10, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This was the first full week in January and the first non-holiday week since December 23rd. All the same, 2025 has started with a bang...